Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd be happy to drive over there, light up the Bat-Signal, and guide the state authorities to their homes.
GLTA
A bunch of ENZC posts on this used hardare direction at the ENZC page on Twitter/X.com
The part about the toxicology tests on IPV-1 came from the horse's mouth: CCC, spoken to me personally.
Sorry, best I can do, but Zhabilov shut the labs when word got out about his ITV-1 product failure, after all of these years.
GLTA
Please be aware, ENZC has NO biotech to speak of at this moment. Zhabilov's ITV-1 failed toxicology tests and has been tossed into the back freezer as a shelf decoration. IPF-Immune also does not work. Clone3 and Clone7, and all other monoclonal antibody research material is over parked at the new MABS-Tech under Cotropia's watchful eye. not part of ENZC currently.
So, there is no biotech at all, right now, at ENZC, just a shell and some stories about turning into a hardware distributor. That could change, and that's where the speculation sits.
GLTY
Initials are most likely,.... HZ.
Yeah, but we still love ya! I wasn't even thinking of you when I posted, I was thinking about a couple of idiots I saw on Twitter going crazy over that old matter.
GLTU!
Yeah, but even this is a half-step on the AI side alone, and the AI side is quite suspect at this point. It was the intel platform they collaborated on and became able to map the HIV and SARS viruses, maybe more we don't know about. Khapley AI is considered a suspect platform, even by some tech experts using it, so only time will tell there. Chandra's entire AI suite of platforms is based upon that. That AI would only accelerate such mappings and new drug options for consideration, not create them.
With no data published on Clone3/7, many have a strong case to bash this one.
Let's hope we're right and not blind.
GLTA
True, can't believe Zimbler is even coming back up. I've asked Chandra to get published data out, even as a private group if he must. With nothing published as respected fact regarding successful use of Clone3 and Clone7, even if just in lab testing results, that would cement the position they can make it move forward. Without that, the risk is high and getting a significant and inked partnership is a pipe dream. Shareholders won't move much on this ticker anymore until some form of respectable published data hits the wires, and an EU patent award projection is made.
The other 2 items I asked him to make a PR on, could wait a bit, but those first two are crucial.
In prior PRs and social media announcements, and private talks, we've been assured Clone3 and Clone7 are working well, both passed toxicology tests with 100% efficacy of no danger factors. But no verification data, just one-sided stories at this point. They've had 5 years now in their 'modern era' of tweaking both CloneX products, so they have no excuse. More years of development prior to that. There are no more excuses for them on the CCC side to not get serious.
I've also offered them an angle of some serious clout and free publicity. It's gone widely ignored. That makes me question why (?) To provide what I'm offering them, I have to lay my personal and professional reputations on the line, and I won't do it unless they can give me some sort of professional verifications of what they promise. They are way past Chandra's redundant theory and potential futures prose. That's not an insult aimed at Chandra or anyone else, just a bare, raw fact they can't ignore.
I've got one other investigative maneuver I can try, no more in-person visits to abandoned labs at Texas A&M, but something more direct.
GLTA
Me too, and I'll deal with the red buzzer itching the back of my brain.
I agree completely with all of that Dawg, but one major concern pecks in the back of my brain regularly, and it's a very reasonable conflict.
With no published data of successful testing, of any significant kind, there is no proof they actually have what they claim, and it has been many years now. Any reasonable published test results, even lab testing results, would validate that both Clone3 and Clone7 are working well and ready to move forward. THAT ALONE, could cement forward movement here. A projection on EU patent awards, would add sizzle to pps upswings, when the situation is live again.
We have to decide just how mindless management is on all sides, or that they possibly are a scam and we're all super-duped. I lean very much along your direction, my similar direction and that of others here, but I have to remain a realist. I offered them some clout to get things going, and I was politely ignored on that out-of-hand, very strange. The politics behind it are well in CCC's favor, if they've been truthful as we expect they have been. When they turn down great, free publicity and clout that can assist them in great ways to get not only into final trials but to market with emphasis, what does that tell you?
I'm not certain myself, maybe they don't understand what I offered to do, but I'm concerned they were not even interested, twice now.
If Dr. Chandra is reading this one, I do hope he calls to discuss it. All sorts of investors and friends of the company offering to help them, and they go silent. What I've offered, could be tactically scheduled to positively synch with their own internal efforts, and they need all the help they can get at this point.
GLTY!
That of course works too, but from just a business standpoint, if CCC was to merge a new company with ENZC and honor all ENZC common shares 1:1, then they'd want the fullest value they could get before making the new company public.
It's a doable gamble, but if anything goes wrong, their own shares go so low it may be self-destructive. It's just an Alice in Wonderland nightmare trying to predict lesser minds running PINK:OTC companies. Charles Cotropia alone should have been able to stop this.
GLTY!
Get your SEC complaint filed electronically now with the old link on this page. I don't have it handy at present, farting around online right now at an airport waiting on my flight.
Get that done first and use only Zhabilov's name for starters. If you complain about the CCC bunch who's no longer legally there, your complaint won't get but a second's look by anyone monitoring the growing list.
Then find anyone setting up the small class-action of defrauded shareholders. The risk of it not getting past an SEC warning stage to Zhabilov by the SEC, is for the reasons that: (1) it's in OTC:Pink land, so the priority will be low, (2) ENZC may have no assets left to act against as a company, (3) Zhabilov will run if investigated, dragging out a low priority case. If anyone unearths proof he sold off illegally as accused, and got millions out of it, some SEC official would pursue and prosecute. As they did with the old Pink stock "SpongeTech", and sent that guy up for a 10-year federal pen stint, after liquidating all of his personal assets in Florida.
Yep! And who knows, (?) ENZC still has to prove itself after all of these years.
Well, with what you've written just below, your assumption already fell apart. He would not be able to fund any new venture with his IP's, because they're empty fakes as you've indicated.
If he is getting funding in any way, then you're wrong, CCC really does have something. Trading G's and Glows, always wanting it both ways.
GLTA
Can't argue that. Can only reiterate, no such scam has ever spent so much money on research and resources as ENZC obviously did. Scams run off with such money, they don't actually put it into real research.
ENZC did, pointing more likely to BAD MANAGEMENT, IMHO.
I've urged Chandra to come out with 3-4 critical PR's that would prove their worth, but he's sidestepped that for now. Not a good move at such a critical junction. If he or CCC as a whole, answered even 2 of those PR requests, that I may add are LONG OVERDUE, he'd prove their worth and position.
Right now, the Casino has gangsters with itchy trigger fingers at every exit.
GLTA
You just gotta' love today's crap over on 'X':
Enzolytics Inc
@enzolyticsinc
·
9m
These pieces will be the foundation for several strategic acquisitions.
Quote
Enzolytics Inc
@enzolyticsinc
·
10m
In addition to the Sagaliam percentage that $ENZC #ENZC retains, which has significant value, in summary, we are pursing the Nitric Oxide arrangement, the SPAD arrangement with Dr. Tong, the ETC Marketing situation and also RobustoMed.
I'm beginning, just beginning to think they (CCC) knows they'll have voting control soon, and they'll either absorb ENZC into one of their new companies or, most probably, looking over Charles' history, merge Adnexus with ENZC, something like that, so all shareholders are brought aboard.
I don't think it will take forever either, with long, drawn-out legal cases. I think once Harry is out, he bitterly remains in the shadows, letting the new company or ENZC version make his shares, which he'll still have, increase in value.
This could be a win-win for all sides, and I hope any further management failures of personal greed on the Zhabilov portion can be dissipated away. Zhabilov signed off on the IP releases back to the CCC group, which was just a formality, since Cotropia and Chandra owned them personally, so he has NO legal claim he could succeed with, and any ad-hoc suits could be dismissed in simple hearings if he were dumb enough to go back on his separation agreement from this last March.
One thing reinforcing my gut feeling, CCC is showing public disdain, but not out-of-control spite for Harry and seem all-too confident that they are completing all objectives.
Oh crap, this is thin, but for once CCC, prove me right.
GLTA
Yeah, I sent Dr. Chandra 3 items to put at least 'something' of substance out for shareholder confidence, and he passed on all 3 of them with this announcement. While I'm very happy he poked his head out again, this does nothing to move the football down the field. IMHO, we don't need more pump talk about a new version of his AI and website, we need specifics to prove they have something real they can move forward on. I, at many of of our friends' behests here, asked for:
-- Published data of any successful test, lab results or volunteer testing on Clone3 or Clone 7. Even a protective, partial results report that competitors can't take anything IP-related from, but shareholders and industry eyes could respect, is critical. Without any published 'proof' of what they have,, this still goes nowhere.
-- Any news or projections on when the new volunteer trials in South America might commence when the proverbial dust settles.
-- What next steps or milestone schedules will be (Patent Awards, volunteer trials, EU trials, product readiness, partnership movement anything real...) once that dust settles.
If any of the above were addressed, especially the first one, that does not tip off Harry to anything he could do about it, would have made my day.
Disappointingly, CCC - Chandra, sidestepped the norm, a long overdue norm, yet again. Makes me worry about what they're hiding. I so hope I'm wrong, but.....!
GLTA
Maybe Cat, fingers crossed. I have to respect the risk here on ENZC.
I directed X messages over to Chandra today, urging something viable to be posted and 3 items he needs to keep the trust.
-- What are their next steps in moving along Clone3/7 when the dust settles?
-- They have to publish some data on successful testing, even if its lab results only. No published data after decades or development and positive announcements just indicates a con, not a biopharma.
-- When will the new South American Volunteer trials be expected to commence once they do move forward?
If Charles and/or Chandra can answer just 2 of those 3 questions without any mis-directing prose, it would go a long, long way in righting the ship.
And they don't have to speak as ENZC, just as the IP owners.
Yes, and Facebook.
The European patents are due in soon, and they have worth if Clone3 and Clone7 are ready as Chandra indicated. Also, the South American volunteer trials are supposed to get underway once the smoke clears.
Could be a BS story, might be the truth too. The new patents they were waiting on are Euro-Patents, that under the EMA between the states and EU, can accelerate trial approvals in the USA if they prove successful in the EU. That's the way it has been for about 3 years now, the plan, the schedule and now Harry's selloffs/destruction.
Not much to hang a hat on, I agree, but a still slight candle burning at the end of the tunnel. Or, Shara-bs-hura might create a stock spike by promising all of these new tech distribution sales, and having some couple of MM's pump it for him.
GLTA (If it's just a Zombie-ticker, that you've been singing about for almost a year now, why are you biting at the corpse? Infatuation?)
The Cotropias are not Bulgarian, at least not by birth anyway. There are no US records of immigration for either one of them, Joe or Charles. In fact, Joeseph has been in Texas since first year of college, making him about a 40-years-plus Texan. Both have lived all over the USA.
Joseph and Charles have lived a majority of their adult lives in Texas. They may have Bulgarian contacts or a generation-removed set of relatives in Bulgaria, but that's as close as it gets. I did not feel like paying any more money to dig deeper. Both were born in the USA, native citizens of the country.
Zhabilov, well......$#$%R#@R$##!!
PS: The origin of the surname 'Cotropia' is Italian, not Bulgarian. Just FYI.
I read this the other day; my reaction is 100% the same as yours.
GLTY
FU little boy, try proving there never was an NDA. You don't know business for squat, and while this 'may' be a scam, it's obvious you'll never be the one to first know it.
Since you can't handle truth; you sure should not be an investor.
There's always some real facts folks don't like, and saying you don't know for sure, that was accepted by this board with your first posts.
FACTS, there may have been, and probably were NDA's in place, if the partnership talks ever had a day 1. If not, no, no NDA's ever existed. You don't know, so peddle your bashes elsewhere. I respect opposing views, where facts are used, not just hater's conjecture. I'm speculating myself, with simple logic and business practice, that environment you obviously know nothing about.
Maybe, but it was also probably a requirement of Partnership talks, which always require NDA's for this type of conversation. I believe if those were real, and no evidence they were not, they probably were for just those conversations and in effect for whatever duration the conversations stay relevant for potentially future business dealings.
Beyond that, I doubt the NDA's ever covered anything else. With the incestuous relationship ENZC and SAGA has/had, there was no NDA involved there, and the only time NDA's were ever mentioned, was about the time ENZC posted that they were in talks for future partnerships and licensing agreements. Every time my company has to get into a software partnership for new clients, I have NDA's dropped on me, almost before the email exchanges start. The projected figures from any such agreement in Biopharma relations are much higher figures than any $$$ my company ever gets into.
If ENZC decries "NDA issues, we can't divulge yet..." and it's not about conversations with potential partners, yes, I'd suspect that is a lie designed to dodge some embarrassing/sensitive information they don't want to expose or have to expose.
This is nothing new, but saying the NDA's were never real, not smart. They probably were, and probably abused for their own PR/advertising issues online.
GLTA
I P-M'ed you.
Gilead, a potential partnership suitor for ENZC, just took a big step forward with its HIV prevention drug candidate, now if ENZC really can cure a case of HIV in a patient, with their mABS Clone3, a partnership would give Gilead a virtual monopoly on curing cases of AIDS.
Dr. Chandra, you watching? Forget congratulations to others for unrelated things this week, huh ??
And here's the link: https://www.biospace.com/article/gilead-s-twice-yearly-shot-shows-100-percent-efficacy-in-phase-iii-hiv-trial-in-women-/?s=61&utm_campaign=Newsletter%20%7C%20GenePool&utm_medium=email&_hsenc=p2ANqtz-9JFOs6gmZTqjCSR_bnifoQKnn7m8y0c9zMJk4mC4eo5Ewhs_LOLgL2N6nII5xrGK40Xd4jzB15ISZNY-AUdWT6styifw&_hsmi=312476080&utm_content=312476080&utm_source=hs_email
I fully agree, they are long overdue to have volunteer trial results and published data for what's been said both in PR's and directly by their own words, public and private.
No pure scam puts out as much money as they did to operate amongst other peer companies where they were at. No well-engineered scam bothers to see that much money come in, and put it out to credible vendors and suppliers, labor and other misc. costs. They have done that.
But perhaps terrible management (?) Could very well be. Unfortunately, we don't have enough info, and they're well on the clock because of that shortcoming.
Clone 3 and 7 allegedly passed all toxicology testing back in 2021 and 22. But even that data did not hit public purview. Makes one worry and frustrated with the most justifiable reasons and realities.
CCC needs to step up fast, or any legal issues they have coming will be well deserved. I'm a stickler for the truth, no more, no less. Just not enough of that going around now.
Just reported the facts CS, A&M staff I spoke with said they were doing continuous research work in both labs before leaving. Showed me the average pricing for leasing and maintaining both labs, and they were paid in full before ENZC left.
They did seem surprised at the ENZC abrupt departure, but would not go into it further. This is as you might expect when you dump everything and leave your host fast.
My data is accurate. Supplied pictures and videos of my being there.
It may dispel the claim that it's always been a well-engineered scheme, but not to worry, without any published data or volunteer trials in the bank, so to speak, it does definitely talk to very bad biopharma management. Either they have it working, or they don't.
GLTA
Hope you're right, sure sounded strange to me.
So, the CCC contingent paid over $600K+ for operational use of 2 labs at Texas A&M, an office in Plano, TX, plus employee salaries, while not many still.... and a lot of research resources and supplier bills for over 2 years while still present in College Station, Texas.
No scam anywhere does that.
FACT.
While it's now a scam under Harry Zhabilov alone, and true that even the CCC gang has not delivered anything concrete to the marketplace, not even published data, the CCC core group was/is not a scam at this point and time.
You have proof otherwise, provide it. Yes, I see some very bad management in this deal, just not sure where all of that liability is held. And ENZC right now is a joke, but some of us want to wait-n-see. Look at the numbers, none of us are scooping up more shares despite the low, low pps.
GLTA
I see from this morning's early post, King of Prussia decided to lose all legitimacy, LOL. He just endorsed every BS-PR that ENZC has let loose recently. What a business plan there KoP !! The new ENZC will save us all!
Fair enough. It's well overdue that he and the CCC group publish data showing Clone3 and Clone7 working well. They could even do that as one of their two shell companies, MABS-Tech would be the proper choice. They could still re-assign the IP's back to ENZC at a later date if all goes well.
No more excuses left.
GLTA
TRUTH, even the fake holiday.
COMPARATIVE NOTES FOR TODAY:
Gilead's top contender in the mABS market, once bragged upon and pumped endlessly for investors and their biopharma futures, Magolimab, a top cancer fighting product, took a nose dive this week, showing toxicology and a higher likelihood of death set of issues. All Clinical Stage 1 testing has been put on hold. Stage II indefinitely delayed for now.
This Magrolimab product, was Gilead's leading research and product line to begin a large procession of mABS therapeutics and possibly cures. Now its going nowhere after more testing and analysis has been orderd up to see what's next for Gilead.
I hope Dr. Chandra caught sight of this development, one of the potential partnership suitors just hit a wall with their own top mABS therapeutic candidate. Opportunities....
GLTA
https://www.biospace.com/article/gilead-s-magrolimab-ineffective-linked-to-increase-risk-of-death-in-mds-patients/?utm_campaign=Newsletter%20%7C%20GenePool&utm_medium=email&_hsenc=p2ANqtz-8UI3j5puZ2dGw19iNTUUC-hYAA5yf9BLiwm6iOMb9mszDCVjhTUK5EAuohii6iLfj-9OitCLSyYpmmDMLvlzgsXRevSQ&_hsmi=311924366&utm_content=311924366&utm_source=hs_email
His old "rugged PC and Tablet business" he folded into the ground was almost as PINK as one could get, but he started out with better financing initially. He's born for the OTC racket. Robutomed did nothing but house old documents. Sharabura oversaw that... lol.... he's probably running origami or macramé classes out of a garage right now.
LMAO, BGEN has not pumped or announced anything since Summer of last year.
Poor try, already common knowledge.
It could mean that, it could also mean that other legal liabilities may leave ENZC up for the grabbing, and they're about to be in position.
No doubt. I'm still giving 20:1 odds that Sharabura is the first one to disappear to some other pink operation.
GLTA